Victrelis

Merck's Experimental Hepatitis C Drug Beats Victrelis

Merck's Experimental Hepatitis C Drug Beats Victrelis

Bloomberg

Merck CEO assures shareholders there is life after death of Singulair patent

Merck CEO assures shareholders there is life after death of Singulair patent

Fierce Pharma

Two Hepatitis C Treatments Win U.K. Health-Cost Agency Backing

Two Hepatitis C Treatments Win U.K. Health-Cost Agency Backing

Bloomberg

Merck's hepatitis C drug wins UK cost endorsement

Merck's hepatitis C drug wins UK cost endorsement

Reuters

Merck Hepatitis C Drug May `Anchor' Future Worldwide Regimen

Merck Hepatitis C Drug May `Anchor' Future Worldwide Regimen

Bloomberg

Dendreon to sell royalty in Merck hep C drug

Dendreon to sell royalty in Merck hep C drug

Reuters

Dendreon, Merck's Hepatitis C Drug: Future Prospects Look Encouraging

Dendreon, Merck's Hepatitis C Drug: Future Prospects Look Encouraging

Seeking Alpha

Vertex Bests Merck in New Hepatitis C Drug Sales

Vertex Bests Merck in New Hepatitis C Drug Sales

NY Times, NY

Merck says Victrelis working in HIV patients

Merck says Victrelis working in HIV patients

CNBC

Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market

Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market

TheStreet.com